During the past decade, Päijät-Häme Central Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 4 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Päijät-Häme Central Hospital" #1 sponsor was "Joint Authority for Päijät-Häme Social and Health Care" with 10 trials, followed by "Helsinki University Central Hospital" with 5 trials sponsored, "University of Helsinki" with 3 trials sponsored, "Oulu University Hospital" with 2 trials sponsored and "PaijatHame Central Hospital" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Päijät-Häme Central Hospital" #1 collaborator was "Helsinki University Central Hospital" with 5 trials as a collaborator, "Tampere University" with 4 trials as a collaborator, "Tampere University Hospital" with 3 trials as a collaborator, "Turku University Hospital" with 3 trials as a collaborator and "Finnish Cultural Foundation" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Päijät-Häme Central Hospital" are "Atrial Fibrillation" (2 trials), "Colorectal Cancer" (2 trials), "Actinic Keratoses" (1 trials), "Actinic Keratosis" (1 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Päijät-Häme Central Hospital" in a lesser frequency.

Most popular intervention types in "Päijät-Häme Central Hospital" are "Drug" (13 trials), "Procedure" (9 trials), "Other" (8 trials), "Device" (4 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Conservative treatment" (2 trials), "5-aminolevulinic acid nanoemulsion" (1 trials), "A highly hydrolyzed formula" (1 trials) and "A regular cow's milk based formula" (1 trials). Other intervention names were less common.

The vast majority of trials in "Päijät-Häme Central Hospital" are 33 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Päijät-Häme Central Hospital". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Päijät-Häme Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Päijät-Häme Central Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 16 trials that are defined as “Not Applicable".